Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 235,811 | 216,209 | 197,562 | 193,841 | 191,518 |
| Accounts receivable | -76,684 | -134,278 | -106,511 | 19,346 | -129,195 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | -247,632 | 210,708 |
| Other Working Capital | 16,738 | 44,784 | -462,127 | -708,076 | 1,405 |
| Other Operating Activity | 1,575,723 | 1,274,545 | 1,064,375 | 1,093,668 | 462,282 |
| Operating Cash Flow | $1,751,588 | $1,401,260 | $693,299 | $351,147 | $736,718 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -89,865 | -99,460 | -119,672 | -134,835 | -102,712 |
| Net Acquisitions | -139,248 | -133,464 | -1,012,749 | -42,784 | -39,067 |
| Purchase Of Investment | -6,416 | -22,464 | -32,229 | -37,900 | -21,788 |
| Sale Of Investment | 46,261 | 1,000 | 19,133 | 6,802 | 19,219 |
| Purchase Sale Intangibles | -10,777 | -15,396 | -14,328 | -21,201 | -14,114 |
| Investing Cash Flow | $-200,045 | $-269,784 | $-1,159,845 | $-229,918 | $-158,462 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 105,000 | 1,070,000 | 288,000 | 90,000 |
| Debt Repayment | -40,000 | -835,000 | -405,000 | -166,000 | -612,000 |
| Common Stock Issued | 74,439 | 53,094 | 49,142 | 47,384 | 37,790 |
| Common Stock Repurchased | -300,025 | -150,011 | N/A | N/A | 0 |
| Dividend Paid | -310,880 | -282,320 | -258,276 | -245,341 | -226,713 |
| Other Financing Activity | -29,787 | -10,050 | -32,992 | -52,406 | -53,709 |
| Financing Cash Flow | $-606,253 | $-1,119,287 | $422,874 | $-128,363 | $-764,632 |
| Exchange Rate Effect | 25,799 | -1,719 | -2,147 | -14,434 | 18,498 |
| Beginning Cash Position | 238,361 | 227,891 | 273,710 | 295,278 | 463,156 |
| End Cash Position | 1,209,450 | 238,361 | 227,891 | 273,710 | 295,278 |
| Net Cash Flow | $945,290 | $12,189 | $-43,672 | $-7,134 | $-186,376 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,751,588 | 1,401,260 | 693,299 | 351,147 | 736,718 |
| Capital Expenditure | -100,642 | -114,856 | -134,000 | -156,036 | -116,826 |
| Free Cash Flow | 1,650,946 | 1,286,404 | 559,299 | 195,111 | 619,892 |